|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
1993
|
|
gptkbp:ATCCode
|
B01AB05
|
|
gptkbp:CASNumber
|
9005-49-6
|
|
gptkbp:chemicalFormula
|
C26H42N2O36S5
|
|
gptkbp:contraindication
|
history of heparin-induced thrombocytopenia
active major bleeding
|
|
gptkbp:drugBank
|
DB01225
|
|
gptkbp:drugClass
|
low molecular weight heparin
|
|
gptkbp:eliminatedIn
|
renal
|
|
gptkbp:genericName
|
gptkb:enoxaparin
|
|
gptkbp:halfLife
|
4.5 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lovenox
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Sanofi
|
|
gptkbp:mechanismOfAction
|
inhibits factor Xa
inhibits thrombin
|
|
gptkbp:medlinePlus
|
a601202
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
intravenous injection
|
|
gptkbp:sideEffect
|
gptkb:anemia
bleeding
thrombocytopenia
|
|
gptkbp:UNII
|
S7286QZG3A
|
|
gptkbp:usedFor
|
gptkb:acute_coronary_syndrome
treatment of deep vein thrombosis
treatment of pulmonary embolism
prevention of deep vein thrombosis
prevention of pulmonary embolism
|
|
gptkbp:bfsParent
|
gptkb:Rhône-Poulenc
|
|
gptkbp:bfsLayer
|
6
|